




Searching News Database: IPX066
HSMN NewsFeed - 6 Apr 2018
Impax Launches a Generic Version of Estrace(R) Cream (estradiol vaginal cream, USP, 0.01%)
Impax Launches a Generic Version of Estrace(R) Cream (estradiol vaginal cream, USP, 0.01%)
HSMN NewsFeed - 26 Apr 2017
Impax Announces FDA Approval and Launch of a Generic Version of Vytorin(R) (Ezetimibe/Simvastatin Tablets)
Impax Announces FDA Approval and Launch of a Generic Version of Vytorin(R) (Ezetimibe/Simvastatin Tablets)
HSMN NewsFeed - 13 Apr 2016
Impax Announces Availability of EMVERM(TM) (mebendazole) Chewable Tablets, 100 mg
Impax Announces Availability of EMVERM(TM) (mebendazole) Chewable Tablets, 100 mg
HSMN NewsFeed - 15 Jan 2016
Impax Receives Approval of EMVERM(TM) (mebendazole) Chewable Tablets, 100 mg
Impax Receives Approval of EMVERM(TM) (mebendazole) Chewable Tablets, 100 mg
HSMN NewsFeed - 17 Sep 2015
Impax Receives FDA Approval for Generic Version of Mestinon(R) Timespan(R) Tablets, 180 mg
Impax Receives FDA Approval for Generic Version of Mestinon(R) Timespan(R) Tablets, 180 mg
HSMN NewsFeed - 21 Dec 2011
Impax Pharmaceuticals Submits New Drug Application for IPX066 in Parkinson’s Disease
Impax Pharmaceuticals Submits New Drug Application for IPX066 in Parkinson’s Disease
HSMN NewsFeed - 15 Apr 2010
Impax Pharmaceuticals Completes Enrollment in APEX-PD Phase III Trial of IPX066 in Parkinson's Disease
Impax Pharmaceuticals Completes Enrollment in APEX-PD Phase III Trial of IPX066 in Parkinson's Disease